Barinthus Biotherapeutics plc Strategic Asset Allocation Index
Barinthus Biotherapeutics plc strategic asset allocation index. Barinthus Biotherapeutics plc (BRNS) has a Strategic Asset Allocation Index of 5.9% as of September 2022. Strategic assets (PP&E of $14.32 Million plus long-term investments of $-) total $14.32 Million, measured against net assets of $244.15 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BRNS net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Barinthus Biotherapeutics plc (2021–2021)
Strategic asset allocation index of Barinthus Biotherapeutics plc from 2021 to 2021. This chart shows how Barinthus Biotherapeutics plc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 5.9%, representing strategic assets of $14.32 Million against net assets of $244.15 Million USD. Check tangible equity quality of Barinthus Biotherapeutics plc to evaluate the tangible quality of the company's equity base.
Barinthus Biotherapeutics plc Strategic Asset Allocation Index by Year (2021–2021)
Barinthus Biotherapeutics plc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Barinthus Biotherapeutics plc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Barinthus Biotherapeutics plc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.7% | $1.83 Million | $1.83 Million | $- | $252.56 Million | — |